Kensey Nash Predicts Orthopedic Growth In 2006 After Orthovita Disappoints
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash expects that updating the Vitoss Foam bone-void filler line will revive sluggish sales to biomaterials company Orthovita in 2006